Kenneth E Weg - Net Worth and Insider Trading
Kenneth E Weg Net Worth
The estimated net worth of Kenneth E Weg is at least $202,500 dollars as of 2024-11-13. Kenneth E Weg is the Director of AVEO Pharmaceuticals Inc and owns about 13,500 shares of AVEO Pharmaceuticals Inc (AVEO) stock worth over $202,500. Details can be seen in Kenneth E Weg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kenneth E Weg has not made any transactions after 2010-03-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kenneth E Weg
Kenneth E Weg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kenneth E Weg owns 2 companies in total, including Karyopharm Therapeutics Inc (KPTI) , and AVEO Pharmaceuticals Inc (AVEO) .
Click here to see the complete history of Kenneth E Weg’s form 4 insider trades.
Insider Ownership Summary of Kenneth E Weg
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2013-11-05 | director |
| AVEO | AVEO Pharmaceuticals Inc | 2010-03-11 | director |
Kenneth E Weg Latest Holdings Summary
Kenneth E Weg currently owns a total of 1 stock. Kenneth E Weg owns 13,500 shares of AVEO Pharmaceuticals Inc (AVEO) as of March 11, 2010, with a value of $202,500.
Latest Holdings of Kenneth E Weg
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AVEO | AVEO Pharmaceuticals Inc | 2010-03-11 | 13,500 | 15.00 | 202,500 |
Holding Weightings of Kenneth E Weg
Kenneth E Weg Form 4 Trading Tracker
According to the SEC Form 4 filings, Kenneth E Weg has made a total of 0 transactions in AVEO Pharmaceuticals Inc (AVEO) over the past 5 years. The most-recent trade in AVEO Pharmaceuticals Inc is the sale of 0 shares on March 11, 2010, which brought Kenneth E Weg around $0.
Insider Trading History of Kenneth E Weg
- 1
Kenneth E Weg Trading Performance
Kenneth E Weg Ownership Network
Ownership Network List of Kenneth E Weg
Ownership Network Relation of Kenneth E Weg
Kenneth E Weg Owned Company Details
What does Karyopharm Therapeutics Inc do?
Who are the key executives at Karyopharm Therapeutics Inc?
Kenneth E Weg is the director of Karyopharm Therapeutics Inc. Other key executives at Karyopharm Therapeutics Inc include director & President and CEO Richard A. Paulson , EVP & CFO & Treasurer Michael Mason , and SVP Sales & Commercial Ops Sohanya Roshan Cheng .
Karyopharm Therapeutics Inc (KPTI) Insider Trades Summary
Over the past 18 months, Kenneth E Weg made no insider transaction in Karyopharm Therapeutics Inc (KPTI). Other recent insider transactions involving Karyopharm Therapeutics Inc (KPTI) include a net sale of 165,682 shares made by Richard A. Paulson , a net sale of 55,845 shares made by Michael Mason , and a net sale of 41,559 shares made by Sohanya Roshan Cheng .
In summary, during the past 3 months, insiders sold 27,326 shares of Karyopharm Therapeutics Inc (KPTI) in total and bought 0 shares, with a net sale of 27,326 shares. During the past 18 months, 2,078,182 shares of Karyopharm Therapeutics Inc (KPTI) were sold and 41,140 shares were bought by its insiders, resulting in a net sale of 2,037,042 shares.
Karyopharm Therapeutics Inc (KPTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Karyopharm Therapeutics Inc Insider Transactions
Kenneth E Weg Mailing Address
Above is the net worth, insider trading, and ownership report for Kenneth E Weg. You might contact Kenneth E Weg via mailing address: Clearview Projects, One Palmer Square, Suite 436, Princeton Nj 08542.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
